Literature DB >> 28532051

Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery.

Rahul Pratap Singh1, Gunjan Sharma2, Sanjay Singh3, Shreekant Bharti4, Bajarangprasad L Pandey1, Biplob Koch5, Madaswamy S Muthu6.   

Abstract

The aim of this work was to formulate chitosan-folate conjugated multi-walled carbon nanotubes for the lung cancer targeted delivery of docetaxel. The chitosan-folate conjugate was synthesized and the conjugation was confirmed by Fourier transform infrared spectroscopy. The multi-walled carbon nanotubes were characterized for their particle size, polydispersity, zeta potential, surface morphology, drug encapsulation efficiency and in vitro release study. The in vitro cellular uptake, cytotoxicity, and cell cycle analysis of the docetaxel/coumarin-6 loaded multi-walled carbon nanotubes were carried out to compare the effectiveness of the formulations. The biocompatibility and safety of chitosan-folate conjugated multi-walled carbon nanotubes was analyzed by lung histopathology in comparison with marketed docetaxel formulation (Docel™) and acylated multi-walled carbon nanotubes. The cellular internalization study shown that the chitosan-folate conjugated multi-walled carbon nanotubes could be easily internalized into the lung cancer cells through a folate receptor-mediated endocytic pathway. The IC50 values exhibited that chitosan-folate conjugated multi-walled carbon nanotubes could be 89-fold more effective than Docel™ in human lung cancer cells (A549 cells).
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan-folate conjugate; Lung cancer; MWCNT; Nanotechnology; Safety

Mesh:

Substances:

Year:  2017        PMID: 28532051     DOI: 10.1016/j.msec.2017.03.225

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  7 in total

1.  Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy.

Authors:  Wei Pei; Ling Cai; Xing Gong; Li Zhang; Jiarong Zhang; Ping Zhu; Huijun Jiang; Chao Wang; Shoulin Wang; Jin Chen
Journal:  Mater Today Bio       Date:  2022-05-04

Review 2.  Eco-friendly synthesis of carbon nanotubes and their cancer theranostic applications.

Authors:  Ebrahim Mostafavi; Siavash Iravani; Rajender S Varma; Mehrdad Khatami; Fatemeh Rahbarizadeh
Journal:  Mater Adv       Date:  2022-05-16

Review 3.  Carbon Graphitization: Towards Greener Alternatives to Develop Nanomaterials for Targeted Drug Delivery.

Authors:  Davide Marin; Silvia Marchesan
Journal:  Biomedicines       Date:  2022-06-04

Review 4.  A Review on Chitosan's Uses as Biomaterial: Tissue Engineering, Drug Delivery Systems and Cancer Treatment.

Authors:  Rayssa de Sousa Victor; Adillys Marcelo da Cunha Santos; Bianca Viana de Sousa; Gelmires de Araújo Neves; Lisiane Navarro de Lima Santana; Romualdo Rodrigues Menezes
Journal:  Materials (Basel)       Date:  2020-11-06       Impact factor: 3.623

Review 5.  Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer.

Authors:  Matte Kasi Viswanadh; Rahul Pratap Singh; Poornima Agrawal; Abhishesh Kumar Mehata; Datta Maroti Pawde; Roshan Sonkar; Madaswamy Sona Muthu
Journal:  Nanotheranostics       Date:  2018-01-01

Review 6.  The Applications of Carbon Nanotubes in the Diagnosis and Treatment of Lung Cancer: A Critical Review.

Authors:  Mojgan Sheikhpour; Maryam Naghinejad; Alibakhsh Kasaeian; Armaghan Lohrasbi; Seyed Sadegh Shahraeini; Shahab Zomorodbakhsh
Journal:  Int J Nanomedicine       Date:  2020-09-24

Review 7.  Microfluidics for core-shell drug carrier particles - a review.

Authors:  Sepideh Yazdian Kashani; Amir Afzalian; Farbod Shirinichi; Mostafa Keshavarz Moraveji
Journal:  RSC Adv       Date:  2020-12-23       Impact factor: 3.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.